Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol versus allopurinol + tadalafil for cavernosal uric acid in vasculogenic erectile dysfunction
PACTR202506591686874Completed
- Sponsor
- Al-Azhar University
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of allopurinol and tadalafil in Vascular Erectile Dysfunction (3 arms), sponsored by Al-Azhar University. Primary endpoints: Change in cavernosal uric acid levels and Change in IIEF-5 score. Started Mar 2023; status: completed.
02
Drugs
allopurinoltadalafil
03
Conditions
Vascular Erectile Dysfunction
Beyond the preview
Go deeper on PACTR202506591686874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202506591686874.